US Patent 11977073 HLA G-modified cells and methods
Patent 11977073 was granted and assigned to AgeX Therapeutics on May, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11977073 HLA G-modified cells and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.